American Technology Research Reinstates Coverage on Covanta (CVA) with a Buy
More News related to CVA
- Covanta SECONN Earns OSHA Honors for Workplace Safety and Health Excellence
- Covanta Announces Amended Terms for its Acquisition of Two Biomass Energy Facilities in Maine
- Covanta Reopens the Tulsa Energy-from-Waste Facility
- Covanta Energy Wins 2008 WTERT Industry Award
- CEVA SATA IP Deployed in Freescale's PowerQUICC II Pro Communications Product Line
More News related to New Coverage
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
American Technology Research reinstates coverage on Covanta (NYSE: CVA) with a Buy. Price target $30.
Covanta Holding Corporation, through its subsidiaries, provides waste and energy services in the United States, Europe, and Asia.
Related Categories
New CoverageStocks Mentioned
-0.12Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
